Back
Regeneron Pharmaceuticals Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
46
REGN
Regeneron Pharmaceuticals
Last Price:
$614.93
Seasonality Move:
8.29%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REGN is experiencing buying pressure, which is a positive indicator for future bullish movement.
Regeneron Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 571.56 | Buy |
20-day SMA: | 582.27 | Buy |
50-day SMA: | 606.48 | Sell |
200-day SMA: | 815.95 | Sell |
8-day EMA: | 581.51 | Buy |
20-day EMA: | 581.33 | Buy |
50-day EMA: | 606.56 | Sell |
200-day EMA: | 748.24 | Sell |
Regeneron Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -5.19 | Sell |
Relative Strength Index (14 RSI): | 52.97 | Buy |
Chaikin Money Flow: | 439729 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (556.96 - 598.9) | Buy |
Bollinger Bands (100): | (594.4 - 709.14) | Sell |
Regeneron Pharmaceuticals Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Regeneron Pharmaceuticals Stock
Is Regeneron Pharmaceuticals Stock a Buy?
-
Regeneron Pharmaceuticals share price is 596.54 while REGN 8-day simple moving average is 571.56, which is a Buy signal.
-
The stock price of REGN is 596.54 while Regeneron Pharmaceuticals 20-day SMA is 582.27, which makes it a Buy.
-
Regeneron Pharmaceuticals 50-day simple moving average is 606.48 while REGN share price is 596.54, making it a Sell technically.
-
REGN stock price is 596.54 and Regeneron Pharmaceuticals 200-day simple moving average is 815.95, creating a Sell signal.
REGN Technical Analysis vs Fundamental Analysis
Sell
46
Regeneron Pharmaceuticals (REGN)
is a Sell
Is Regeneron Pharmaceuticals a Buy or a Sell?
-
Regeneron Pharmaceuticals stock is rated a SellThe current Regeneron Pharmaceuticals [REGN] share price is $596.54. The Score for REGN is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
Regeneron Pharmaceuticals Stock Info
Market Cap:
64.4B
Price in USD:
596.54
Share Volume:
666.3K
Regeneron Pharmaceuticals 52-Week Range
52-Week High:
1,211.20
52-Week Low:
520.50
Sell
46
Regeneron Pharmaceuticals (REGN)
is a Sell
Regeneron Pharmaceuticals Share Price Forecast
-
What is the Regeneron Pharmaceuticals stock price today?The Regeneron Pharmaceuticals stock price is 596.54 USD today.
-
Will REGN stock go up or go down?Regeneron Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Regeneron Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Regeneron Pharmaceuticals is overvalued.
Is Regeneron Pharmaceuticals Stock a Buy?
-
Regeneron Pharmaceuticals share price is 596.54 while REGN 8-day exponential moving average is 581.51, which is a Buy signal.
-
The stock price of REGN is 596.54 while Regeneron Pharmaceuticals 20-day EMA is 581.33, which makes it a Buy.
-
Regeneron Pharmaceuticals 50-day exponential moving average is 606.56 while REGN share price is 596.54, making it a Sell technically.
-
REGN stock price is 596.54 and Regeneron Pharmaceuticals 200-day simple moving average is 748.24, creating a Sell signal.
Fundamental Analysis of Regeneron Pharmaceuticals
Is Regeneron Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $1.35 per share, a decrease next quarter of $0.26 per share, a decrease this year of $9.42 per share, and an increase next year of $4.85 per share.
Technical Analysis of Regeneron Pharmaceuticals
Should I short Regeneron Pharmaceuticals stock?
-
REGN Moving Average Covergence Divergence (MACD) indicator is -5.19, suggesting Regeneron Pharmaceuticals is a Sell
-
Regeneron Pharmaceuticals Relative Strength Index (RSI) is 52.97, which suggest Regeneron Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Regeneron Pharmaceuticals is (556.96 - 598.9), which suggest Regeneron Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Regeneron Pharmaceuticals is (594.4 - 709.14), which suggest Regeneron Pharmaceuticals is a Sell
* Regeneron Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.